U.S. flag

An official website of the United States government

NM_003070.5(SMARCA2):c.669GCA[16] (p.Gln238_Pro239insGlnGlnGln) AND multiple conditions

Germline classification:
Likely benign (1 submission)
Last evaluated:
Nov 17, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002493272.8

Allele description [Variation Report for NM_003070.5(SMARCA2):c.669GCA[16] (p.Gln238_Pro239insGlnGlnGln)]

NM_003070.5(SMARCA2):c.669GCA[16] (p.Gln238_Pro239insGlnGlnGln)

Gene:
SMARCA2:SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
9p24.3
Genomic location:
Preferred name:
NM_003070.5(SMARCA2):c.669GCA[16] (p.Gln238_Pro239insGlnGlnGln)
HGVS:
  • NC_000009.12:g.2039779GCA[16]
  • NG_032162.2:g.64490GCA[16]
  • NG_115850.1:g.121GCA[16]
  • NM_001289396.2:c.669_671GCA[16]
  • NM_001289397.2:c.669GCA[16]
  • NM_003070.5:c.669GCA[16]MANE SELECT
  • NM_139045.4:c.669GCA[16]
  • NP_001276325.1:p.Gln238_Pro239insGlnGlnGln
  • NP_001276325.1:p.Gln238_Pro239insGlnGlnGln
  • NP_001276326.1:p.Gln238_Pro239insGlnGlnGln
  • NP_003061.3:p.Gln238_Pro239insGlnGlnGln
  • NP_620614.2:p.Gln238_Pro239insGlnGlnGln
  • LRG_882t1:c.669GCA[16]
  • LRG_882:g.64490GCA[16]
  • LRG_882p1:p.Gln238_Pro239insGlnGlnGln
  • NC_000009.11:g.2039776_2039777insCAGCAGCAG
  • NC_000009.11:g.2039779GCA[16]
  • NM_001289396.1:c.669GCA[16]
  • NM_003070.3:c.666_667insCAGCAGCAG
  • NM_003070.3:c.699_707dupGCAGCAGCA
  • NM_003070.5:c.699_707dupMANE SELECT
Links:
dbSNP: rs113070757
NCBI 1000 Genomes Browser:
rs113070757
Molecular consequence:
  • NM_001289396.2:c.669_671GCA[16] - inframe_indel - [Sequence Ontology: SO:0001820]
  • NM_001289397.2:c.669GCA[16] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_003070.5:c.669GCA[16] - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_139045.4:c.669GCA[16] - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Name:
Nicolaides-Baraitser syndrome (NCBRS)
Synonyms:
Intellectual disability-sparse hair-brachydactyly syndrome
Identifiers:
MONDO: MONDO:0011053; MedGen: C1303073; Orphanet: 3051; OMIM: 601358
Name:
Blepharophimosis-impaired intellectual development syndrome
Identifiers:
MONDO: MONDO:0859139; MedGen: C5443984; OMIM: 619293

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002800977Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Nov 17, 2021)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002800977.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 9, 2024